146 related articles for article (PubMed ID: 38286404)
21. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
22. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
[TBL] [Abstract][Full Text] [Related]
23. Concordance of p16
Mena M; Wang X; Tous S; Quiros B; Clavero O; Alejo M; Morey F; Taberna M; Leon Vintro X; Lloveras Rubio B; Alos L; Mehanna H; Quint W; Pawlita M; Tommasino M; Pavón MA; Muñoz N; De Sanjose S; Bosch FX; Alemany L; On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954451
[TBL] [Abstract][Full Text] [Related]
24. Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer.
Ma Y; Wang C; Shi M; Li M; Li L; Che T; Qu J
Mol Clin Oncol; 2022 Oct; 17(4):149. PubMed ID: 36157320
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer.
Yoshida H; Murono S; Ueno T; Nakanishi Y; Tsuji A; Hatano M; Endo K; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
Acta Otolaryngol; 2017 Jul; 137(7):773-777. PubMed ID: 28093931
[TBL] [Abstract][Full Text] [Related]
26. Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study.
Dickey BL; Giuliano AR; Sirak B; Abrahamsen M; Lazcano-Ponce E; Villa LL; Coghill AE
J Infect Dis; 2023 Jan; 227(2):256-260. PubMed ID: 35679351
[TBL] [Abstract][Full Text] [Related]
27. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
Taberna M; Torres M; Alejo M; Mena M; Tous S; Marquez S; Pavón MA; León X; García J; Guix M; Hijano R; Bonfill T; Aguilà A; Lozano A; Mesía R; Alemany L; Bravo IG
Front Oncol; 2018; 8():589. PubMed ID: 30619735
[No Abstract] [Full Text] [Related]
28. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
[TBL] [Abstract][Full Text] [Related]
29. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review.
Day AT; Fakhry C; Tiro JA; Dahlstrom KR; Sturgis EM
JAMA Otolaryngol Head Neck Surg; 2020 Jul; 146(7):656-664. PubMed ID: 32379293
[TBL] [Abstract][Full Text] [Related]
30. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA
Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534
[TBL] [Abstract][Full Text] [Related]
31. Promoter Hypermethylation of Tumor-Suppressor Genes
Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
[TBL] [Abstract][Full Text] [Related]
32. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
[TBL] [Abstract][Full Text] [Related]
33. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
[TBL] [Abstract][Full Text] [Related]
34. Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study.
Bettampadi D; Sirak BA; Abrahamsen ME; Reich RR; Villa LL; Ponce EL; Giuliano AR
Clin Infect Dis; 2021 Nov; 73(9):e3227-e3234. PubMed ID: 33173937
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation profiling identifies epigenetic differences between early versus late stages of diabetic chronic kidney disease.
Lecamwasam A; Novakovic B; Meyer B; Ekinci EI; Dwyer KM; Saffery R
Nephrol Dial Transplant; 2021 Nov; 36(11):2027-2038. PubMed ID: 33146725
[TBL] [Abstract][Full Text] [Related]
36. High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study.
Prétet JL; Dalstein V; Touzé A; Beby-Defaux A; Soussan P; Jacquin É; Birembaut P; Clavel C; Mougin C; Rousseau A; Lacau Saint Guily J;
Clin Exp Med; 2023 Feb; 23(1):87-96. PubMed ID: 35199231
[TBL] [Abstract][Full Text] [Related]
37. A CpG Methylation Signature as a Potential Marker for Early Diagnosis of Hepatocellular Carcinoma From HBV-Related Liver Disease Using Multiplex Bisulfite Sequencing.
Li K; Song Y; Qin L; Li A; Jiang S; Ren L; Zang C; Sun J; Zhao Y; Zhang Y
Front Oncol; 2021; 11():756326. PubMed ID: 34745991
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
D'Souza G; Tewari SR; Troy T; Waterboer T; Struijk L; Castillo R; Wright H; Shen M; Miles B; Johansson M; Robbins HA; Fakhry C
Cancer; 2023 Aug; 129(15):2373-2384. PubMed ID: 37032449
[TBL] [Abstract][Full Text] [Related]
39. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
40. DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma.
Sorroche BP; Talukdar FR; Lima SCS; Melendez ME; de Carvalho AC; de Almeida GC; De Marchi P; Lopes M; Ribeiro Pinto LF; Carvalho AL; Herceg Z; Arantes LMRB
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
